Lorigan, Paul
Green, Adele C.
Article History
First Online: 25 April 2017
Competing interests
: P.L. is a member of the European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group, where he chairs the Advanced Disease Subgroup. He had no involvement in EORTC 18071 trial, did not recruit patients to the trial, and was not privy to the results until they were published. P.L. has acted as a paid consultant/adviser to Amgen, BMS, GSK, MSD, Novartis, and Roche. He has received support for travel from BMS and MSD. A.G. declares no competing interests.